Donghe Han

Prof. Dr. Donghe Han


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
MJMeihua Jin
Meihua Jin
CWChun Wang
Chun Wang
YXYifeng Xu
Yifeng Xu
ZZZijing Zhang
Zijing Zhang
XWXueyan Wu
Xueyan Wu
DHDonghe Han
Donghe Han
Salidroside (SAL) is a phenylpropanoid glycoside monomer extracted from Rhodiola at high altitudes. It has been proven to have protective effects on myocardial injury, liver cancer, renal fibrosis, and other organ diseases, as well as play neuroprotective roles in central nervous system (CNS) diseases. Specifically, SAL can inhibit a series of pathological reactions in CNS diseases and improve neurological dysfunction. This review elucidated the pharmacological effects of SAL on inflammation, oxidative stress, apoptosis, autophagy, and neuronal regeneration. Furthermore, how SAL affects various signaling pathways to regulate pathological processes in CNS diseases is also assessed. However, the relationship between various pathways and the mechanisms in different pathological stages remains unclear. Additionally, the appropriate dosage and side effects of SAL on the clinical outcomes of CNS diseases have not been fully determined due to the limited number of clinical studies on SAL. Therefore, the regulatory mechanisms and clinical applications of SAL still need to be further demonstrated. This review tracked and summarized studies from the past eight years reported in databases, including PubMed, ScienceDirect, and Google Scholar, filtered using the keywords "salidroside" and/or paired with "diseases" and "CNS diseases".

1 April 2017 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MJMeihua Jin
Meihua Jin
PLPengfei Lv
Pengfei Lv
GCGuanyu Chen
Guanyu Chen
PWPeng Wang
Peng Wang
ZZZhongfu Zuo
Zhongfu Zuo
DHDonghe Han
Donghe Han

1 October 2018 in Toxicology Letters
Verified
Journal Article
Closed access
MJMeihua Jin
Meihua Jin
JLJing Lou
Jing Lou
HYHuihui Yu
Huihui Yu
MMMiao Miao
Miao Miao
GWGuangchuan Wang
Guangchuan Wang
GYGuang Yu
Guang Yu

16 April 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
QZQianqian Zhao
Qianqian Zhao
MJMeihua Jin
Meihua Jin
QZQiang Zhao
Qiang Zhao
ZWZhimei Wang
Zhimei Wang
CZChun Zhao
Chun Zhao
RTRan Tao
Ran Tao
Renal fibrosis represents the terminal pathological manifestation of most chronic kidney diseases, driving progressive loss of renal function. Natural products have emerged as promising therapeutic agents for preventing and ameliorating renal fibrosis due to their multi-target efficacy and favorable safety profiles. In this review, we conducted a comprehensive literature search on PubMed using the keywords “natural product” and “renal fibrosis” from 2004 to 2025, identifying 704 relevant articles. We systematically categorize and discuss the biological effects of key natural products and formulations with antifibrotic potential, focusing on five major classes: glycosides, flavonoids, phenolic compounds, anthraquinones, and terpenoids. Representative compounds from each category are highlighted for their mechanisms of action, including modulation of oxidative stress, inflammation, autophagy, and fibrosis signaling pathways. This review aims to provide a theoretical foundation for the development of natural product-based therapies to combat renal fibrosis, offering insights into their therapeutic potential and future research directions.

12 October 2026 in Chinese Medical Journal
Verified
Journal Article
Open access
QZQianqian Zhao
Qianqian Zhao
MJMeihua Jin
Meihua Jin
QZQiang Zhao
Qiang Zhao
XZXinyue Zhao
Xinyue Zhao
YGYujiao Gao
Yujiao Gao
DHDonghe Han
Donghe Han
Was not provided for this article.